Pharmacokinetics of Voriconazole in Obese Subjects
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Obese subjects may require a higher fixed oral maintenance dosing regimen of voriconazole
compared to normal weight subjects to achieve comparable plasma exposures. The current study
is designed to address this issue.
Phase:
Phase 4
Details
Lead Sponsor:
Albany College of Pharmacy and Health Sciences Manjunath Prakash Pai